Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Treatment of obesity|
|Abstract:||N,N-dimethyl-1-[ 1-(4-chlorophenyl)cyclobutyl] -3-methylbutylamine hydrochloride is used in the treatment of obesity in humans.|
|Inventor(s):||Scheinbaum; Monte L. (Shreveport, LA)|
|Assignee:||The Boots Company (USA), Inc. (Shreveport, IN)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Delivery;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||94385||<disabled in preview>|
|Australia||4620789||<disabled in preview>|
|Australia||633529||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.